Condiciones de salud que Olive oil puede ayudar a apoyar.
EVOO is rich in polyphenols (hydroxytyrosol, oleuropein, tyrosol) and vitamin E that directly scavenge free radicals and upregulate endogenous antioxidant enzymes. EFSA has issued a health claim for EVOO polyphenols protecting blood lipids from oxidative damage. Multiple human trials confirm measurable increases in plasma antioxidant capacity following EVOO consumption.
Oleic acid in olive oil is metabolically converted to oleoylethanolamide (OEA) in the gut, which activates PPARα receptors to signal satiety to the hypothalamus. Clinical studies show EVOO-rich diets reduce post-meal hunger ratings compared to diets high in saturated fat. These mechanisms contribute to olive oil's role in sustainable appetite regulation.
Olive oil (extra virgin) is rich in oleic acid, hydroxytyrosol, and oleuropein—compounds shown to improve endothelial function, reduce arterial stiffness, lower blood pressure, and protect against atherosclerosis. Multiple RCTs and the PREDIMED study support olive oil's role in reducing cardiovascular events. The 2024 PMC vascular health literature review confirms polyphenols from olive oil improve endothelial function.
EVOO polyphenols, particularly oleocanthal, have well-documented anti-inflammatory mechanisms relevant to arthritis, including COX inhibition. Human epidemiological data link Mediterranean diet with EVOO to lower arthritis prevalence. In vitro studies confirm EVOO polyphenolic extracts suppress key inflammatory mediators in synovial tissue.
Olive oil polyphenols—particularly hydroxytyrosol, oleuropein, and oleocanthal—inhibit platelet aggregation through multiple mechanisms in both in vitro and human clinical studies. EVOO boosts apoA-IV, which counteracts post-prandial platelet activation. A human study using hydroxytyrosol-rich extract demonstrated a 47% reduction in thromboxane B2 after 4 days.
Both experimental and human clinical studies demonstrate anti-hypertensive effects of olive oil. EVOO's oleic acid and antioxidant polyphenols contribute to blood pressure reduction through improved endothelial function and nitric oxide bioavailability. A 2025 EFSA review supports olive oil phenolics in reducing systolic blood pressure.
Clinical trials confirm EVOO reduces postprandial glucose excursions and improves fasting blood glucose and HbA1c. PREDIMED data show Mediterranean diet with EVOO prevents diabetes onset. Olive oil polyphenols modulate alpha-glucosidase activity and enhance insulin signaling.
Human cross-sectional and cohort studies demonstrate a positive association between olive oil intake and volumetric bone mineral density (vBMD). A Spanish women cohort found significant positive correlations between olive oil intake and total, trabecular, and cortical bone density. Human studies show daily olive oil consumption can prevent decline in bone mineral density.
Human RCTs and meta-analyses confirm that EVOO and its phenolic compounds improve lipid profiles, particularly by reducing LDL cholesterol and increasing HDL function. High-phenolic EVOO shows more pronounced effects than low-phenolic refined olive oil. EFSA reviewed RCTs supporting olive oil polyphenols' effect on LDL-cholesterol reduction.
EVOO and its polyphenols (oleocanthal, hydroxytyrosol, oleuropein) are extensively documented to reduce systemic inflammatory biomarkers in human clinical trials. Oleocanthal inhibits COX-1 and COX-2 in a manner analogous to ibuprofen. A meta-analysis of 30 human intervention studies confirmed amelioration of inflammatory and antioxidant status across a broad population.
Multiple clinical studies support EVOO's neuroprotective role, including a small RCT showing improved clinical dementia ratings and blood-brain barrier function in mild cognitive impairment. PREDIMED sub-studies link Mediterranean diet with EVOO to better memory and frontal cognition. Epidemiological data associate higher olive oil intake with lower neurodegenerative disease risk.
Clinical studies confirm that olive oil (typically 1–2 tablespoons daily) effectively relieves constipation by lubricating the intestinal tract and stimulating intestinal motility. A clinical study in hemodialysis patients found olive oil as effective as mineral oil for constipation management. Traditional Mediterranean use of olive oil as a gentle laxative is well documented.
Topical olive oil has traditionally been used for dermatitis, including diaper dermatitis. RCT evidence supports olive oil use in contact and diaper dermatitis. However, clinical evidence for atopic dermatitis indicates potential for barrier disruption, while olive oil polyphenols retain anti-inflammatory properties relevant to inflammatory dermatitis.
Olive oil has been evaluated in several clinical studies for diaper dermatitis. A triple-blind RCT (Sharifi-Heris et al., 2018, Dermatologic Therapy, e12731) compared olive oil and calendula ointments directly for diaper dermatitis. An earlier study in 173 children (cited in PMC3346674) showed significantly lower frequency of diaper rash with olive oil versus control.
Lycopene-enriched virgin olive oil spray was evaluated in a double-blind RCT of 60 elderly patients with drug-induced xerostomia over 12 weeks. The treatment group showed significant improvements in speaking difficulty, perceived saliva amount, and lip dryness on the Xerostomia Inventory, though resting salivary flow rate did not change. Olive oil's lubricating fatty acid composition provides oral coating.
Topical olive oil has been traditionally and clinically used to moisturize dry skin, with its fatty acid composition providing occlusive and emollient properties. However, RCT evidence shows that while olive oil can temporarily improve hydration, its high oleic acid content may increase transepidermal water loss with prolonged use on some skin types.
Evidence on topical olive oil for eczema is genuinely mixed and largely cautionary. Well-cited RCTs show olive oil can damage the stratum corneum barrier and worsen atopic dermatitis, while some anti-inflammatory effects have been documented. The National Eczema Association and National Eczema Society do not recommend topical olive oil for eczema due to barrier disruption concerns.
Olive oil phenolic compounds selectively promote beneficial gut bacteria, increase alpha diversity, and enhance short-chain fatty acid production. A 2026 prospective cohort of 656 older adults linked virgin olive oil consumption to beneficial gut microbiota composition and improved cognitive outcomes. EVOO also strengthens intestinal barrier integrity.
Epidemiological and clinical evidence links olive oil consumption to reduced all-cause mortality and better aging outcomes. EVOO's polyphenols counteract oxidative stress and neuroinflammation, two hallmarks of aging. PREDIMED data and Mediterranean cohort studies consistently associate higher olive oil intake with longevity.
Clinical evidence suggests EVOO-rich Mediterranean diets modestly support healthy weight and body composition compared to low-fat diets, particularly reducing visceral fat. A 2018 double-blind RCT found EVOO improved body composition and blood pressure in women with excess body fat. Meta-analytic data show EVOO-enriched diets reduce waist circumference and BMI.
Olive oil, especially EVOO, is one of the most evidence-backed dietary components for cardiovascular protection. The landmark PREDIMED trial demonstrated significant reductions in major cardiovascular events with daily EVOO use. Multiple meta-analyses confirm an inverse dose-response between olive oil consumption and cardiovascular mortality. EVOO polyphenols protect LDL from oxidation, improve endothelial function, and modulate several cardiac risk factors.
EVOO consumption reduces postprandial glycemic response, improves HOMA-IR, and enhances insulin signaling at the gene expression level. PREDIMED data show EVOO intake prevents diabetes onset. An RCT in Type 1 diabetes patients showed EVOO significantly blunted glycemic response to a high-glycemic-index meal.
EVOO consumption has been associated with preserved memory function in aging adults in both RCTs and epidemiological studies. A 2022 RCT in mild cognitive impairment showed EVOO improved behavioral scores and enhanced brain activation in cortical regions involved in memory. PREDIMED data link olive oil supplementation to improved memory and frontal cognition.
Multiple RCTs and meta-analyses demonstrate that EVOO, as part of a Mediterranean diet, improves the key components of metabolic syndrome: blood pressure, fasting glucose, insulin resistance, lipid profile, and waist circumference. Olive polyphenols independently (beyond lipid content) reduce metabolic syndrome risk factors.
Olive oil and its polyphenols have demonstrated bone-protective effects in animal models of osteoporosis and in human observational studies. Hydroxytyrosol inhibits multinucleated osteoclast formation and suppresses trabecular bone loss in ovariectomized animal models. Human data link olive oil intake to improved bone mineral density and fracture reduction.
EVOO polyphenolic extracts suppress key RA-relevant inflammatory pathways in vitro, including MMP-1, MMP-3, COX-2, IL-6, and TNF-α in IL-1β-activated synovial fibroblasts. Epidemiological data from Mediterranean populations link high olive oil consumption with lower RA prevalence. Anti-inflammatory polyphenols in EVOO are considered promising dietary adjuncts to RA management.
EVOO's polyphenols, vitamin E, and squalene counteract UV-induced photoaging and oxidative skin damage that drives wrinkle formation. Epidemiological data from Mediterranean populations suggest dietary EVOO intake is associated with fewer signs of skin aging. EVOO's antioxidant compounds protect dermal fibroblasts from oxidative damage that degrades collagen and elastin.
Olive oil's polyphenols and fatty acids support dermal collagen integrity by inhibiting MMP activity and reducing oxidative degradation of collagen fibers. Squalene in EVOO has documented skin-softening and barrier-protective properties. Dietary EVOO consumption is associated in epidemiological data with better skin elasticity in older populations.
EVOO's squalene, vitamin E, and polyphenols provide antioxidant protection against UV-induced oxidative damage in skin when consumed dietarily or applied topically. Squalene in EVOO specifically protects against singlet oxygen generated by UV exposure. Mediterranean populations consuming high EVOO show epidemiologically lower rates of UV-related skin damage.
Olive oil, a cornerstone of the Mediterranean diet, reduces triglycerides through its high MUFA content (oleic acid) and polyphenols. Multiple RCTs and meta-analyses confirm TG reduction with regular olive oil consumption. The PREDIMED trial (n=7,447) confirmed lipid benefits of olive oil in high-cardiovascular-risk individuals.
Topical olive oil has been traditionally used to promote wound healing, and clinical studies support its use for specific wound types including diabetic foot ulcers. Olive's anti-inflammatory and antioxidant phenolics promote epithelial repair. A PMC review of randomized trials in diabetic foot ulcers, pressure ulcers, and episiotomy wounds found olive oil to be an effective topical treatment.
Volver